Molecular subtypes and antifungal susceptibilities of serial Cryptococcus neoformans isolates in human immunodeficiency virus-associated cryptococcosis

Journal of Infectious Diseases

Volumn 174, Issue 4, 1996, Pages 812-820

  Brandt, Mary E ^a   Pfaller, Michael A ^b   Hajjeh, Rana A ^b   Graviss, Edward A ^b   Rees, Judy ^b   Spitzer, Eric D ^b   Pinner, Robert W ^b   Mayer, Leonard W ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; FLUCYTOSINE; FUNGAL DNA;

ADULT; ARTICLE; CLINICAL ARTICLE; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DNA POLYMORPHISM; DRUG SENSITIVITY; ELECTROPHORESIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KARYOTYPING; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; REINFECTION;

EID: 0029836385     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/174.4.812     Document Type: Article

References (27)

1. Panther LA, Sande MA. Cryptococcal meningitis in the acquired immuno-deficiency syndrome. Semin Respir Infect 1990;5:138-45.
2. Sugar AM. Overview: cryptococcosis in the patient with AIDS. Mycopathologia 1991;14:153-7.
3. Grant IH, Armstrong D. Fungal infections in AIDS: cryptococcosis. Infect Dis Clin North Am 1988;2:457-64.
4. Pinner RW, Hajjeh RA, Powderly WG. Prospects for the prevention of cryptococcosis in persons infected with human immunodeficiency virus. Clin Infect Dis 1995;1(suppl 1):S103-7.
5. Powderly WG. Therapy for cryptococcal meningitis in patients with AIDS. Clin Infect Dis 1992;14(suppl 1):S54-9.
6. Larsen RA, Bozzette S, McCutchan A. Persistent Cryptococcus neoformans infection of the prostate after successful treatment of meningitis. Ann Intern Med 1989;111:125-8.
7. Bozzette SA, Larsen RA, Chiu J, et al. Fluconazole treatment of persistent Cryptococcus neoformans prostatic infection in AIDS. Ann Intern Med 1991;115:285-6.
8. Bailly MP, Boibieux A, Biron F. Persistence of Cryptococcus neoformans in the prostate: failure of fluconazole despite high doses. J Infect Dis 1991;164:435-6.
9. Ndimbie OK, Dekker A, Martinez AJ, Dixon B. Prostatic sequestration of Cryptococcus neoformans in immunocompromised persons treated for cryptococcal meningoencephalitis. Histol Histopathol 1994;9:643-8.
10. Spitzer ED, Spitzer SO, Freundlich LF, Casadevall A. Persistence of initial infection in recurrent Cryptococcus neoformans meningitis. Lancet 1993;341:595-6.
11. Varma A, Swinne D, Staib F, et al. Diversity of DNA fingerprints in Cryptococcus neoformans. J Clin Microbiol 1995;33:1807-14.
12. Barchiesi F, Hollis RJ, Messer SA, et al. Electrophoretic karyotype and in vitro antifungal susceptibility of Cryptococcus neoformans isolates from AIDS patients. Diagn Microbiol Infect Dis 1995;23:99-103.
13. Haynes KA, Sullivan DJ, Coleman DC, et al. Involvement of multiple Cryptococcus neoformans strains in a single episode of cryptococcosis and reinfection with novel strains in recurrent infection demonstrated by random amplification of polymorphic DNA and fingerprinting. J Clin Microbiol 1995;33:99-102.
14. Wingard JR, Merz WG, Rinaldi MG, et al. Increase in Candida krusei among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med 1991;325: 1274-7.
15. Casadevall A, Spitzer ED, Webb D. Susceptibilities of serial Cryptococcus neoformans isolates from patients with recurrent cryptococcal meningitis to amphotericin B and fluconazole. Antimicrob Agents Chemother 1993:37:1383-6.
16. Powderly WG, Keath EJ, Sokol-Anderson M, et al. Amphotericin B-resistant Cryptococcus neoformans in a patient with AIDS. Infect Dis Clin Pract 1993;1:314-6.
17. Paugam A, Dupouy-Camet J, Blanche P, et al. Increased fluconazole resistance of Cryptococcus neoformans isolated from a patient with AIDS and recurrent meningitis. Clin Infect Dis 1994;19:975-6.
18. Brandt ME, Hutwagner LC, Kuykendall RJ, et al. Comparison of multilocus enzyme electrophoresis and random amplified polymorphic DNA analysis for molecular subtyping of Cryptococcus neoformans. J Clin Microbiol 1995;33:1890-5.
19. Brandt ME, Hutwagner LC, Klug LA, et al. Molecular subtype distribution of Cryptococcus neoformans in four areas of the United States. J Clin Microbiol 1996;34:912-7.
20. Kwon-Chung KJ, Polacheck I, Bennett JE. Improved diagnostic medium for separation of Cryptococcus neoformans var. neoformans (serotypes A and D) and Cryptococcus neoformans var. gattii (serotypes B and C). J Clin Microbiol 1982;15:535-7.
21. Brandt ME, Bragg SL, Pinner RW. Multilocus enzyme typing of Cryptococcus neoformans. J Clin Microbiol 1993;31:2818-23.
22. Perfect JR, Magee BB, Magee PT. Separation of chromosomes of Cryptococcus neoformans by pulsed field gel electrophoresis. Infect Immun 1989;57:2624-7.
23. Varma A, Kwon-Chung KJ. Rapid method to extract DNA from Cryptococcus neoformans. J Clin Microbiol 1991;29:810-2.
24. Pfaller MA, Hollis RJ, Sader HS. Chromosomal restriction fragment analysis by pulsed-field gel electrophoresis. In: Isenberg HD, ed. Clinical microbiology procedures handbook. Suppl 1. Washington, DC: American Society for Microbiology, 1994:10.5.C.1-10.5.C.12.
25. Spitzer ED, Spitzer SG. Use of a dispersed repetitive DNA element to distinguish clinical isolates of Cryptococcus neoformans. J Clin Microbiol 1992;30:1094-7.
26. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing for yeasts. Proposed standard. Document M27-P. Villanova, PA: NCCLS, 1992.
27. Pfaller MA, Grant C, Morthland V. Comparative evaluation of alternative methods for broth dilution susceptibility testing of fluconazole against Candida albicans. J Clin Microbiol 1994;32:506-9.